NEW YORK (AP) — A Goldman Sachs analyst said Tuesday that Express Scripts Holding Co. is poised for strong profit growth for the rest of this decade after the pharmacy benefits manager completed its acquisition of former competitor Medco Health Solutions.
THE OPINION: Analyst Robert Jones said the $29.1 billion deal makes Express Scripts a "dominant" company in health care. He said the St. Louis company's per-share profit should grow more than 20 percent per year through 2015 and should rise by at least 10 percent per year through 2020.
Jones resumed coverage of Express Scripts stock with a "Buy" rating and placed the stock on the Conviction List, a portfolio of highly recommended stocks. Jones also set a price target of $70 per share.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
